Title matches "Pharmaceutical" AND Sets matches any of "LSE Health", "LSE Health and Social Care", "NIHR School for Social Care Research", "Personal Social Services Research Unit (PSSRU)"

Export 79 results as BibTeXEndNoteHTML CitationReferReference Manager	RSS 1.0 Atom RSS 2.0

1.	Panteli, Dimitra, Arickx, Francis, Cleemput , Irina, Dedet, Guillaume, Eckhardt, Helene, Fogarty, Emer, Gerkens, Sophie, Henschke, Cornelia, Hislop , Jennifer, Jommi, Claudio, Kaitelidou, Daphne, Kawalec, Pawel, Keskimäki, Ilmo, Kroneman, Madelon, Lopez Bastida , Julio, Pita Barros , Pedro, Ramsberg, Joakim, Schneider , Peter, Spillane, Susan, Vogler, Sabine, Vuorenkoski , Lauri, Wallach Kildemoes, Helle, Wouters, Olivier J. and Busse, Reinhard (2016) Pharmaceutical regulation in 15 European countries: review. Health Systems in Transition, 18 (5). pp. 1-118. ISSN 1817-6127	Preview
2.	Vogler, Sabine, Zimmermann, Nina, Ferrario, Alessandra, Wirtz, Veronika J., de Joncheere, Kees, Bak Pedersen, Hanne, Dedet, Guillaume, Paris, Valérie, Mantel-Teeuwisse, Aukje K. and Babar, Zaheer-Ud-Din (2016) Pharmaceutical policies in a crisis? Challenges and solutions identified at the PPRI Conference. Journal of Pharmaceutical Policy and Practice, 9 (9). ISSN 2052-3211	Preview
3.	Angelis, Aris and Kanavos, Panos (2015) Large scale mergers and acquisitions in the pharmaceutical industry: 1 + 1 = 1? Health and Social Care Blog (12 Nov 2015) Blog Entry.	Preview
4.	Cylus, Jonathan, Wouters, Olivier J. and Kanavos, Panos (2015) Understanding the role of governance in the pharmaceutical sector: from laboratory to patient. In: Greer, Scott, Wismar, Matthias and Figueras, Josep, (eds.) Strengthening Health System Governance: Better Policies, Stronger Performance. Open University Press , Maidenhead, UK, pp. 175-187. ISBN 9780335261345 Not available from LSE Research Online.
5.	Naci, Huseyin, Carter, Alexander W. and Mossialos, Elias (2015) Double failure: the shared accountability of governments and firms for the innovation deficit in the pharmaceutical sector. BMJ . ISSN 1756-1833 (In Press) Item availability restricted.
6.	Vogler, Sabine, Zimmermann, Nina, Ferrario, Alessandra, Wirtz, Veronika J and Babar, Zaheer-Ud-Din (2015) Challenges and opportunities for pharmaceutical pricing and reimbursement policies. Journal of Pharmaceutical Policy and Practice, 8 (Suppl ). ISSN 2052-3211	Preview
7.	Wouters, Olivier J. and Kanavos, Panos G. (2015) Transitioning to a national health system in Cyprus: a stakeholder analysis of pharmaceutical policy reform. Bulletin of the World Health Organization, 93 (9). pp. 606-613. ISSN 0042-9686	Preview
8.	Kanavos, Panos and Angelis, Aris (2014) Acquiring pharmaceutical industry assets in the UK: 1 + 1 = 1? Pharmaceutical Medicine, online . ISSN 1178-2595	Preview
9.	Kanavos, Panos and Wouters, Olivier J. (2014) Pharmaceutical policies in Cyprus: a review of the current system and future options. World Health Organisation, Copenhagen, Denmark.	Preview
10.	Vandoros, Sotiris and Kanavos, Panos (2014) Parallel trade and pharmaceutical prices: a game-theoretic approach and empirical evidence from the European Union. The World Economy, 37 (6). pp. 856-880. ISSN 0378-5920 Not available from LSE Research Online.
11.	Kanavos, Panos and Wouters, Olivier J. (2014) Pharmaceutical parallel trade: legal, policy, and economic issues. In: Culyer, Anthony J., (ed.) Encyclopedia of health economics. Elsevier, San Diego, USA, pp. 20-28. ISBN 9780123756787 Not available from LSE Research Online.
12.	Ferrario, Alessandra, Sautenkova, Nina, Bezverhni, Zinaida, Seicas, Rita, Habicht, Jarno, Kanavos, Panos and Safta, Vladimir (2014) An in-depth analysis of pharmaceutical regulation in the Republic of Moldova. Journal of Pharmaceutical Policy and Practice, 7 (1). p. 4. ISSN 2052-3211	Preview
13.	Kanavos, Panos and Wouters, Olivier J. (2014) Competition issues in the distribution of pharmaceuticals. In: OECD Global Forum on Competition, 27-28 Feb 2014, Paris, France.	Preview
14.	Rudisill, C., Vandoros, Sotiris and Antoun, J. G. (2014) Pharmaceutical policy reform in the Russian federation. Journal of Health Politics, Policy and Law, 39 (3). pp. 691-705. ISSN 0361-6878 Not available from LSE Research Online.
15.	Cerri, Karin H., Knapp, Martin and Fernandez, Jose-Luis (2013) Public funding of pharmaceuticals in the Netherlands: investigating the effect of evidence, process and context on CVZ decision-making. The European Journal of Health Economics, 15 (7). pp. 681-695. ISSN 1618-7598 Not available from LSE Research Online.
16.	Ferrario, Alessandra and Kanavos, Panos (2013) Managed entry agreements for pharmaceuticals: the European experience. EMiNet, Brussels, Belgium.	Preview
17.	Vandoros, Sotiris and Stargardt, Tom (2013) Reforms in the Greek pharmaceutical market during the financial crisis. Health Policy, 109 (1). pp. 1-6. ISSN 0168-8510 Not available from LSE Research Online.
18.	Galizzi, Matteo M., Ghislandi, Simone and Miraldo, Marisa (2012) Effects of reference pricing in pharmaceutical markets. Pharmacoeconomics, 29 (1). pp. 17-33. ISSN 1170-7690 Not available from LSE Research Online.
19.	Naci, Huseyin and Cylus, Jonathan (2012) Why a stricter regulation of drugs could foster (not deter) pharmaceutical innovation. British Politics and Policy at LSE (21 Sep 2012) Blog Entry.	Preview
20.	Varol, Nebibe, Costa-i-Font, Joan and McGuire, Alistair (2012) Does adoption of pharmaceutical innovation respond to changes in the regulatory environment? Applied Economic Perspectives and Policy, 34 (3). pp. 531-553. ISSN 2040-5790 Not available from LSE Research Online.